Sildenafil citrate

• Post Date:

  Mar 20,2019

• Expiry Date:

  Mar 19,2020

• Detailed Description:

  Cas No. :171599-83-0 Quantity: 0.01Kilograms
  Specs:Foil Bag or Tin
  Price:1 USD Kilograms
  Payment Method: Western Union, MoneyGram, T/T
  Sildenafil citrate
  
  CAS: 171599-83-0
  
  Assay: 99% min. USP32
  
  Packing: 1kg/foil bag, 5kg/drum.
  
  Delivery: Express courier.
  
  MF: C28H38N6O11S
  
  MW: 666.7
  
  Character: White Solid. mp 187-189°C
  
  Usage: An orally active selective type 5 cGMP phosphodiesterase inhibitor. pharmaceutical material
  
  Biological Activity: Orally active, potent inhibitor of phosphodiesterase 5 (PDE5) (IC 50 = 4 nM). Enhances nitric oxide-dependent relaxation of human corpus cavernosum in vitro .
  
  Other drugs in same class:Anastrozole,Letrozole,Tamoxifen citrate,Exemestane
  
  Application:
  
  Sildenafil citrate, sold as Viagra, Revatio and under various other trade names, is a drug used to treat erectile dysfunction and pulmonary arterial hypertension (PAH). It was originally discovered by Pfizer scientists Andrew Bell, David Brown, and Nicholas Terrett.
  
  The primary indication of sildenafil is treatment of erectile dysfunction (inability to sustain a satisfactory erection to complete intercourse). Its use is now standard treatment for erectile dysfunction in all settings, including diabetes.

• CAS Registry Number:

  171599-83-0

• Synonyms:

  ;Viagra;5-[2-Ethoxy-5-(4-methylpiperazin-1-yl-sulphonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazol[4,3d]pyrimidin-7-one citrate;5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one 2-hydroxypropane-1,2,3-tricarboxylate (1:1);5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-3-propyl-2,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one;Sidenafil citrate;

• Molecular Formula:

  C₂₁H₂₈N₆O₄S

• Molecular Weight:

  460.5498

• Molecular Structure:

  

• Company:

  Zhuzhou Yuancheng Hezhong Technology Development Co., Ltd.         

• Contact:

  john

• Tel:

  0731-22292033

• Fax:

  0731-22292033

• Email:

  ycgl08@yccreate.com